Investors Press Releases Cardiol Therapeutics Appoints CNBC Market Analyst Steven Grasso as Business Advisor June 29, 2020 David Elsley Files Early Warning Report for Cardiol Therapeutics June 25, 2020 Cardiol Therapeutics Closes $17.25 Million Bought Deal Offering, Including Full Exercise of the Over-Allotment Option June 04, 2020 Cardiol Therapeutics Reports 2020 AGM Results June 02, 2020 Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 1st at 4:30 p.m. EDT May 29, 2020 Cardiol Therapeutics Announces Increase to Previously Announced Bought Deal Public Offering May 14, 2020 Cardiol Therapeutics Announces $11.25 Million Bought Deal Public Offering May 13, 2020 Cardiol Therapeutics Files International Patent Application Covering the Use of Cannabidiol (CBD) to Improve the Outcome of Patients with COVID-19 May 06, 2020 Cardiol Therapeutics Announces Study Demonstrating its Proprietary Nanotechnology Targets Fibrous Tissue in the Heart April 14, 2020 Cardiol Therapeutics Announces Study Results Confirm the Cardioprotective Role of its Pharmaceutical Cannabidiol Formulation in a Model of Heart Failure April 01, 2020 Page 1 of 512345»
